Italian Real-World Study of Epcoritamab in Relapsed or Refractory DLBCL

Clinical trial NCT07393204 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07393204
Sponsor: Andrés José Maria Ferreri
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Relapsed Diffuse Large B-cell Lymphoma (DLBCL)Refractory Diffuse Large B-Cell Lymphoma

Start date: 2025-12-10
Primary completion: 2026-12-10
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.